#apapaperaday Today's pick is a commentary by Gordon Smith on the Evidence in Focus #apaperaday from yesterday so the topic is again Elevidys' approval and the lack of formal evidence and again published in Neurology. DOI: 10.1212/WNL.0000000000213776

#apaperaday First post-holiday Duchenne related paper is a report of American Association of Neurology Guidelines Subcommittee by Oskoui et al on evidence for delandistrogene moxeparvovec (elevidys) for Duchenne muscular dystrophy patients published in Neurology. doi: 10.1212/WNL.0000000000213604